The Nutshell

» cancer and cell & molecular biology

Daily News Roundup

Most Recent

image: New CAR T-Cell Therapy Shows Promise in Trial for Leukemia

New CAR T-Cell Therapy Shows Promise in Trial for Leukemia

By | November 21, 2017

The immunotherapy, which targets CD22 on cancer cells rather than CD19, might prove useful in patients for whom previous T-cell treatments were unsuccessful. 

0 Comments

image: European Research Council Founder, Molecular Biologist Dies

European Research Council Founder, Molecular Biologist Dies

By | November 20, 2017

Fotis Kafatos, a Greek researcher famous for his work on malaria, has died at age 77.

0 Comments

image: Cancer Researcher, Former AACR President Dies

Cancer Researcher, Former AACR President Dies

By | November 13, 2017

Donald Coffey, a longtime professor at Johns Hopkins University, discovered the nuclear matrix within cells and its role in DNA replication.

0 Comments

The report provides evidence that goes against concerns that Monsanto’s popular herbicide, Roundup, is carcinogenic. 

8 Comments

Single-cell analyses from mouse samples detail the changes in cell distribution during infections.

0 Comments

Maintaining dynamic connections among the body’s mitochondria is required for the health and life-extending benefits of low-calorie diets for nematodes.

0 Comments

image: Mass Resignation from <em>Scientific Reports</em>’s Editorial Board

Mass Resignation from Scientific Reports’s Editorial Board

By | November 7, 2017

Nineteen researchers have stepped down after the journal decided not to retract a paper that they say plagiarized the work of a Johns Hopkins biomedical scientist.

4 Comments

Research in human patients and mice reveals the role of the circadian clock in the risk of heart damage at different times of day.

1 Comment

image: <em>Oncotarget</em> Journal Cut from Medline

Oncotarget Journal Cut from Medline

By | October 26, 2017

New papers from a cancer journal once named as a possibly predatory publication will no longer appear in the widely used research database.

0 Comments

image: FDA Approves Second CAR T-Cell Therapy

FDA Approves Second CAR T-Cell Therapy

By | October 19, 2017

The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 

0 Comments

Popular Now

  1. A Newly Identified Species Represents Its Own Eukaryotic Lineage
  2. Telomere Length and Childhood Stress Don’t Always Correlate
  3. Optogenetic Therapies Move Closer to Clinical Use
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

RayBiotech